Search Results - "Still, D"

Mll3 and Mll4 Facilitate Enhancer RNA Synthesis and Transcription from Promoters Independently of H3K4 Monomethylation by Dorighi, Kristel M., Swigut, Tomek, Henriques, Telmo, Bhanu, Natarajan V., Scruggs, Benjamin S., Nady, Nataliya, Still, Christopher D., Garcia, Benjamin A., Adelman, Karen, Wysocka, Joanna

“…Monomethylation of histone H3 at lysine 4 (H3K4me1) and acetylation of histone H3 at lysine 27 (H3K27ac) are correlated with transcriptionally engaged enhancer…”
Get full text

Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline by Apovian, Caroline M, Aronne, Louis J, Bessesen, Daniel H, McDonnell, Marie E, Murad, M. Hassan, Pagotto, Uberto, Ryan, Donna H, Still, Christopher D

“…Objective: To formulate clinical practice guidelines for the pharmacological management of obesity. Participants: An Endocrine Society-appointed Task Force of…”
Get full text

Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists by Mechanick, Jeffrey I., Apovian, Caroline, Brethauer, Stacy, Timothy Garvey, W., Joffe, Aaron M., Kim, Julie, Kushner, Robert F., Lindquist, Richard, Pessah‐Pollack, Rachel, Seger, Jennifer, Urman, Richard D., Adams, Stephanie, Cleek, John B., Correa, Riccardo, Figaro, M. Kathleen, Flanders, Karen, Grams, Jayleen, Hurley, Daniel L., Kothari, Shanu, Seger, Michael V., Still, Christopher D.

“…Objective The development of these updated clinical practice guidelines (CPGs) was commissioned by the American Association of Clinical Endocrinologists…”
Get full text

Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease by Kumashiro, Naoki, Erion, Derek M, Zhang, Dongyan, Kahn, Mario, Beddow, Sara A, Chu, Xin, Still, Christopher D, Gerhard, Glenn S, Han, Xianlin, Dziura, James, Petersen, Kitt Falk, Samuel, Varman T, Shulman, Gerald I

“…Insulin resistance is associated with nonalcoholic fatty liver disease (NAFLD) and is a major factor in the pathogenesis of type 2 diabetes. The development of…”
Get full text

Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and nondiabetic patients by Nadeem, Danial, Taye, Mahdi, Still, Matthew D., McShea, Shannon, Satterfield, Daniel, Dove, James T., Wood, G. Craig, Addissie, Benyam D., Diehl, David L., Johal, Amitpal S., Khara, Harshit S., Confer, Bradley D., Still, Christopher D.

“…Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) promote weight loss by suppressing appetite, enhancing satiety, regulating glucose metabolism, and…”
Get full text

Body mass index and all‐cause mortality among older adults by Cheng, Feon W., Gao, Xiang, Mitchell, Diane C., Wood, Craig, Still, Christopher D., Rolston, David, Jensen, Gordon L.

“…Objective To examine the association between baseline body mass index (BMI, kg/m2) and all‐cause mortality in a well‐characterized cohort of older persons…”
Get full text

A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass by GERHARD, Glenn S, STYER, Amanda M, CRAIG WOOD, G, ROESCH, Stephen L, PETRICK, Anthony T, GABRIELSEN, Jon, STRODEL, William E, STILL, Christopher D, ARGYROPOULOS, George

“…Roux-en-Y gastric bypass (RYGB) in humans can remit type 2 diabetes, but the operative mechanism is not completely understood. In mice, fibroblast growth…”
Get full text

Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study by Still, Christopher D, DO, Wood, G Craig, MS, Benotti, Peter, MD, Petrick, Anthony T, MD, Gabrielsen, Jon, MD, Strodel, William E, MD, Ibele, Anna, MD, Seiler, Jamie, PA, Irving, Brian A, PhD, Celaya, Melisa P, MS, Blackstone, Robin, MD, Gerhard, Glenn S, Prof, Argyropoulos, George, Dr

“…Summary Background About 60% of patients with type 2 diabetes achieve remission after Roux-en-Y gastric bypass (RYGB) surgery. No accurate method is available…”
Get full text

AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p by Gerhard, Glenn S, Hanson, Amanda, Wilhelmsen, Danielle, Piras, Ignazio S, Still, Christopher D, Chu, Xin, Petrick, Anthony T, DiStefano, Johanna K

“…Factors governing the development of liver fibrosis in nonalcoholic steatohepatitis (NASH) are only partially understood. We recently identified adipocyte…”
Get full text

Effects of sustained weight loss on outcomes associated with obesity comorbidities and healthcare resource utilization by Wood, G Craig, Bailey-Davis, Lisa, Benotti, Peter, Cook, Adam, Dove, James, Mowery, Jacob, Ramasamy, Abhilasha, Iyer, Neeraj, Smolarz, B Gabriel, Kumar, Neela, Still, Christopher D

“…Determine the impact of long-term non-surgical weight loss maintenance on clinical relevance for osteoarthritis, cancer, opioid use, and depression/anxiety and…”
Get full text

Prospective Study of Diet Quality and the Risk of Dementia in the Oldest Old by Flores, Ashley C, Jensen, Gordon L, Mitchell, Diane C, Na, Muzi, Wood, G Craig, Still, Christopher D, Gao, Xiang

“…This study examined the associations between overall diet quality and the risk of dementia in a rural cohort among the oldest old. Included in this prospective…”
Get full text

CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading by Chu, Xin, Jin, Qunyan, Chen, Hui, Wood, G Craig, Petrick, Anthony, Strodel, William, Gabrielsen, Jon, Benotti, Peter, Mirshahi, Tooraj, Carey, David J, Still, Christopher D, DiStefano, Johanna K, Gerhard, Glenn S

“…Nonalcoholic fatty liver disease (NAFLD) is a prevalent complication of extreme obesity. Loading of the liver with fat can progress to inflammation and…”
Get full text

Collimation with hollow electron beams by Stancari, G, Valishev, A, Annala, G, Kuznetsov, G, Shiltsev, V, Still, D A, Vorobiev, L G

“…A novel concept of controlled halo removal for intense high-energy beams in storage rings and colliders is presented. It is based on the interaction of the…”
Get full text

Walking Tall: A Narrative Critical Family History of a Grandmother’s Fight for New Normals by Still, Chantae D.

“…In this genealogical narrative, the author researches her deceased maternal grandmother Eula Mae’s life and explores ways that various events created the…”
Get full text

Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance by KUMASHIRO, Naoki, BEDDOW, Sara A, KAHN, Mario, PERLER, Bryce K, PUCHOWICZ, Michelle A, VARA PRASAD MANCHEM, BHANOT, Sanjay, STILL, Christopher D, GERHARD, Glenn S, PETERSEN, Kitt Falk, CLINE, Gary W, SHULMAN, Gerald I, VATNER, Daniel F, SAMUEL, Varman T, MAJUMDAR, Sachin K, CANTLEY, Jennifer L, GUEBRE-EGZIABHER, Fitsum, FAT, Ioana, GUIGNI, Blas, JURCZAK, Michael J, BIRKENFELD, Andreas L

“…We measured the mRNA and protein expression of the key gluconeogenic enzymes in human liver biopsy specimens and found that only hepatic pyruvate carboxylase…”
Get full text

Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes by Samuel, Varman T, Beddow, Sara A, Iwasaki, Takanori, Zhang, Xian-Man, Chu, Xin, Still, Christopher D, Gerhard, Glenn S, Shulman, Gerald I

“…Fasting hyperglycemia in patients with type 2 diabetes mellitus (T2DM) is attributed to increased hepatic gluconeogenesis, which has been ascribed to increased…”
Get full text

Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity by Gerhard, G S, Styer, A M, Strodel, W E, Roesch, S L, Yavorek, A, Carey, D J, Wood, G C, Petrick, A T, Gabrielsen, J, Ibele, A, Benotti, P, Rolston, D D, Still, C D, Argyropoulos, G

“…Objective: The goal of the present study was to identify differences in gene expression between SAT, VAT and EAT depots in Class III severely obese…”
Get full text

Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes by Gerhard, Glenn S, Legendre, Christophe, Still, Christopher D, Chu, Xin, Petrick, Anthony, DiStefano, Johanna K

“…Abstract Nonalcoholic steatohepatitis (NASH) is strongly associated with obesity and type 2 diabetes. The molecular factors underlying the development of…”
Get full text

Perturbations of fibroblast growth factors 19 and 21 in type 2 diabetes by Roesch, Stephen L, Styer, Amanda M, Wood, G Craig, Kosak, Zachary, Seiler, Jamie, Benotti, Peter, Petrick, Anthony T, Gabrielsen, Jon, Strodel, William E, Gerhard, Glenn S, Still, Christopher D, Argyropoulos, George

“…Fibroblast growth factors 19 and 21 (FGF19 and FGF21) have been implicated, independently, in type 2 diabetes (T2D) but it is not known if their circulating…”
Get full text

Bile Acids, FXR, and Metabolic Effects of Bariatric Surgery by Edwards, Michael, Argyropoulos, George A., Still, Christopher D., Noel, Olivier F., Gerhard, Glenn S.

“…Overweight and obesity represent major risk factors for diabetes and related metabolic diseases. Obesity is associated with a chronic and progressive…”
Get full text